Michael Lahn

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Physiology

Disorders

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
O'Brien Peter J; Ramanathan Rajeev; Yingling Jonathan M; Baselga Jose; Rothenberg Mace L; Carducci Michael; Daly Thomas; Adcock Dorothy; Lahn Michael
Analysis and variability of TGFbeta measurements in cancer patients with skeletal metastases.
Hanauske Axel-Rainer; Oberschmidt Olaf; Hanauske-Abel Hartmut; Lahn Michael M; Eismann Ulrike
Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro [corrected] soft-agar cloning experiments.
Paz-Ares Luis; Douillard Jean-Yves; Koralewski Piotr; Manegold Christian; Smit Egbert F; Reyes José Miguel; Chang Gee-Chen; John William J; Peterson Patrick M; Obasaju Coleman K; Lahn Michael; Gandara David R
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Lahn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: O'Brien Peter J; Ramanathan Rajeev; Yingling Jonathan M; Baselga Jose; Rothenberg Mace L; Carducci Michael; Daly Thomas; Adcock Dorothy; Lahn Michael
Analysis and variability of TGFbeta measurements in cancer patients with skeletal metastases.
Biologics : targets & therapy 2008;2(3):563-9.
2007: Hanauske Axel-Rainer; Oberschmidt Olaf; Hanauske-Abel Hartmut; Lahn Michael M; Eismann Ulrike
Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro [corrected] soft-agar cloning experiments.
Investigational new drugs 2007;25(3):205-10.
2006: Paz-Ares Luis; Douillard Jean-Yves; Koralewski Piotr; Manegold Christian; Smit Egbert F; Reyes José Miguel; Chang Gee-Chen; John William J; Peterson Patrick M; Obasaju Coleman K; Lahn Michael; Gandara David R
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1428-34.
2006: Lahn Michael; Sundell Karen; Köhler Gabriele
The role of protein kinase C-alpha in hematologic malignancies.
Acta haematologica 2006;115(1-2):1-8.
2005: Oberschmidt O; Eismann U; Schulz L; Struck S; Blatter J; Lahn M M; Ma D; Hanauske A R
Enzastaurin and pemetrexed exert synergistic antitumor activity in thyroid cancer cell lines in vitro.
International journal of clinical pharmacology and therapeutics 2005;43(12):603-4.
2005: Eismann U; Oberschmidt O; Ehnert M; Fleeth J; Lüdtke F E; Struck S; Schulz L; Blatter J; Lahn M M; Ma D; Niyikiza C; Paoletti P; Hanauske A R
Pemetrexed: mRNA expression of the target genes TS, GARFT and DHFR correlates with the in vitro chemosensitivity of human solid tumors.
International journal of clinical pharmacology and therapeutics 2005;43(12):567-9.
2004: Lahn Michael; Su Chen; Li Shuyu; Chedid Marcio; Hanna Kimberly R; Graff Jeremy R; Sandusky George E; Ma Doreen; Niyikiza Clet; Sundell Karen L; John William J; Giordano Thomas J; Beer David G; Paterson Blake M; Su Eric Wen; Bumol Thomas F
Expression levels of protein kinase C-alpha in non-small-cell lung cancer.
Clinical lung cancer 2004;6(3):184-9.
2004: Lahn M; Sundell K; Gleave M; Ladan F; Su C; Li S; Ma D; Paterson B M; Bumol T F
Protein kinase C-alpha in prostate cancer.
BJU international 2004;93(7):1076-81.
2004: Lahn Michael M; Sundell Karen L
The role of protein kinase C-alpha (PKC-alpha) in melanoma.
Melanoma research 2004;14(2):85-9.
2004: Lahn Michael M; Sundell Karen L; Paterson Blake M
The role of protein kinase C-alpha in malignancies of the nervous system and implications for the clinical development of the specific PKC-alpha inhibitor aprinocarsen (Review).
Oncology reports 2004;11(2):515-22.
2004: Lahn M; Paterson B M; Sundell K; Ma D
The role of protein kinase C-alpha (PKC-alpha) in malignancies of the gastrointestinal tract.
European journal of cancer (Oxford, England : 1990) 2004;40(1):10-20.
2004: Lahn Michael; Köhler Gabriele; Sundell Karen; Su Chen; Li Shuyu; Paterson Blake M; Bumol Thomas F
Protein kinase C alpha expression in breast and ovarian cancer.
Oncology 2004;67(1):1-10.
2004: Hanauske A-R; Sundell Karen; Lahn Michael
The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen.
Current pharmaceutical design 2004;10(16):1923-36.
2003: Lahn Michael; Sundell Karen; Moore Stephanie
Targeting protein kinase C-alpha (PKC-alpha) in cancer with the phosphorothioate antisense oligonucleotide aprinocarsen.
Annals of the New York Academy of Sciences 2003;1002():263-70.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michael Lahn

Research Profile (preview)

Chemicals & Drugs

Physiology

Disorders

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michael Lahn (preview)

All Publications